Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-40371.88%
↓ 561% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
-6106.75%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -40371.88% | -160.5% |
| 2024 | -15497.28% | -1180.5% |
| 2023 | -1210.29% | -486.1% |
| 2022 | -206.49% | +86.1% |
| 2021 | -1490.87% | -119.7% |
| 2020 | -678.47% | -239.0% |
| 2019 | -200.13% | -180.6% |
| 2018 | -71.32% | -238.3% |
| 2017 | 51.58% | +103.7% |
| 2016 | -1392.30% | - |